XML 32 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
C. STOCKHOLDERS EQUITY (Tables)
9 Months Ended
Jun. 30, 2014
C. Stockholders Equity Tables  
Stock options, stock bonuses and compensation granted by the Company
Name of Plan   Total Shares Reserved Under Plans     Plans Reserved for Outstandning Options     Shares Issued as Stock Bonus     Remaining Options/Shares Under Plans  
Incentive Stock Option Plans     1,960,000       1,571,997       N/A       147,303  
Non-Qualified Stock Option Plans     5,680,000       4,408,868       N/A       709,213  
Stock Bonus Plans     1,594,000       N/A       1,015,529       577,715  
Stock Compensation Plan     1,350,000       N/A       996,129       353,871  
Schedule of employees and non-employees stock compensation

 

    Nine months ended June 30,  
    2014     2013  
             
 Employees   $ 1,493,134     $ 2,087,718  
 Non-employees   $ 611,416     $ 364,318  

 

    Three Months Ended June 30,  
    2014     2013  
             
 Employees   $ 462,705     $ 564,369  
 Non-employees   $ 189,906     $ 155,963  

 

Derivative Liabilities, Warrants and Other Options
Warrants   Issue Date   Shares Issuable upon Exercise of Warrants     Exercise Price   Expiration Date   Reference  
                         
Series N   8/18/08   2,844,627   0.53   8/18/15   1  
                         
Series A   6/24/09   130,347     5.00   12/24/14   1  
Schleuning (Series A)   7/8/09   16,750     5.00   1/8/15   1  
Series B   9/4/09   50,000     6.80   9/4/14   1  
Series C   8/20/09 – 8/26/09   463,487     5.50   2/20/15   1  
Series E   9/21/09   71,428     17.50   8/12/14   1  
Series F   10/6/11   1,200,000     4.00   10/6/14   1  
Series G   10/6/11   66,667     4.00   8/12/14   1  
Series H   1/26/12   1,200,000     5.00   8/1/15   1  
Series Q   6/21/12   1,200,000     5.00   12/22/15   1  
Series R   12/6/12   2,625,000     4.00   12/6/16   1  
Series S   10/11/13-12/24/13   23,624,326     1.25   10/11/18   1  
Series T   4/17/14   1,782,057     1.58   10/17/14   1  
Series U   4/17/14   445,514     1.75   10/17/17   1  
                         
Series L   4/18/07   0     7.50   4/17/14   2  
Series L (repriced)   4/18/07   70,000     2.50   4/2/15   2  
                         
Series P   2/10/12   590,001     4.50   3/6/17   3  
                         
Private Investor   7/18/05   37,500     6.50   7/18/14   4  
Warrants held by Officer and Director   6/24/09-7/6/09   349,754     4.00 – 5.00   12/24/14 – 1/6/15   5  
                         
Consultants   2/15/05-4/25/14   195,750     0.85 – 20.00   5/20/14 – 12/27/17   6  
Tabular disclosure of derivative liabilities at fair value
   

June 30,

2014

   

September 30,

2013

 
             
Series A through E warrants   $ 6,105     $ 6,106  
Series N warrants     -       41,501  
Series F and G warrants     12,667       12,667  
Series H warrants     24,000       36,000  
Series Q warrants     48,000       48,000  
Series R warrants     236,250       288,750  
Series S warrants     6,142,325       -  
Series T warrants     160,385       -  
Series U warrants     178,036       -  
                 
Total derivative liabilities   $ 6,807,768     $ 433,024